{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/IOVA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T09:52:10.289Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3588,"canonical_name":"IOVANCE BIOTHERAPEUTICS, INC.","cik":"0001425205","uei":null,"lei":null,"duns":null,"ticker":"IOVA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":37},"count":37,"timeline":[{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — IOVANCE BIOTHERAPEUTICS, INC. — 2026-07-02","url_slug":"/sec/cik-0001425205/8-k/0001104659-26-080409","accession_number":"0001104659-26-080409","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — WEISER MICHAEL — 2026-06-18","url_slug":"/sec/cik-0001221449/4/0001104659-26-075863","accession_number":"0001104659-26-075863","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-18","url_slug":"/sec/cik-0001425205/4/0001104659-26-075858","accession_number":"0001104659-26-075858","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-18","url_slug":"/sec/cik-0001425205/4/0001104659-26-075861","accession_number":"0001104659-26-075861","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"S-3ASR","title":"S-3ASR — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-18","url_slug":"/sec/cik-0001425205/s-3asr/0001104659-26-075778","accession_number":"0001104659-26-075778","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"S-8","title":"S-8 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-18","url_slug":"/sec/cik-0001425205/s-8/0001104659-26-075831","accession_number":"0001104659-26-075831","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"S-8","title":"S-8 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-18","url_slug":"/sec/cik-0001425205/s-8/0001104659-26-075832","accession_number":"0001104659-26-075832","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"8-K","title":"8-K — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-10","url_slug":"/sec/cik-0001425205/8-k/0001104659-26-072408","accession_number":"0001104659-26-072408","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-09","url_slug":"/sec/cik-0001425205/4/0001104659-26-071899","accession_number":"0001104659-26-071899","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-09","url_slug":"/sec/cik-0001425205/4/0001104659-26-071891","accession_number":"0001104659-26-071891","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-09","url_slug":"/sec/cik-0001425205/4/0001104659-26-071895","accession_number":"0001104659-26-071895","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-09","url_slug":"/sec/cik-0001425205/4/0001104659-26-071897","accession_number":"0001104659-26-071897","importance":30},{"ts":"2026-06-05","kind":"sec.insider.f","reporter":"Vogt Frederick G","title":"Interim CEO & General Counsel","shares":6638,"price_per_share":4.23,"usd_value":28079,"security_title":"Common Stock","importance":15.02807874},{"ts":"2026-06-05","kind":"sec.insider.f","reporter":"BILINSKY IGOR","title":"Chief Operating Officer","shares":3976,"price_per_share":4.23,"usd_value":16818,"security_title":"Common Stock","importance":15.01681848},{"ts":"2026-06-05","kind":"sec.insider.f","reporter":"GRAF FINCKENSTEIN FRIEDRICH","title":"Chief Medical Officer","shares":3976,"price_per_share":4.23,"usd_value":16818,"security_title":"Common Stock","importance":15.01681848},{"ts":"2026-06-05","kind":"sec.insider.f","reporter":"Puri Raj K.","title":"Chief Regulatory Officer","shares":3843,"price_per_share":4.23,"usd_value":16256,"security_title":"Common Stock","importance":15.01625589},{"ts":"2026-06-05","kind":"sec.insider.m","reporter":"Vogt Frederick G","title":"Interim CEO & General Counsel","shares":15625,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.m","reporter":"Puri Raj K.","title":"Chief Regulatory Officer","shares":9766,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.m","reporter":"BILINSKY IGOR","title":"Chief Operating Officer","shares":7813,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.m","reporter":"GRAF FINCKENSTEIN FRIEDRICH","title":"Chief Medical Officer","shares":7813,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-03","url_slug":"/sec/cik-0001425205/4/0001104659-26-070149","accession_number":"0001104659-26-070149","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-03","url_slug":"/sec/cik-0001425205/4/0001104659-26-070152","accession_number":"0001104659-26-070152","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-03","url_slug":"/sec/cik-0001425205/4/0001104659-26-070153","accession_number":"0001104659-26-070153","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-06-03","url_slug":"/sec/cik-0001425205/4/0001104659-26-070155","accession_number":"0001104659-26-070155","importance":30},{"ts":"2026-06-01","kind":"sec.insider.f","reporter":"Vogt Frederick G","title":"Interim CEO & General Counsel","shares":17701,"price_per_share":3.96,"usd_value":70096,"security_title":"Common Stock","importance":15.07009596},{"ts":"2026-06-01","kind":"sec.insider.f","reporter":"BILINSKY IGOR","title":"Chief Operating Officer","shares":4473,"price_per_share":3.96,"usd_value":17713,"security_title":"Common Stock","importance":15.01771308},{"ts":"2026-06-01","kind":"sec.insider.f","reporter":"GRAF FINCKENSTEIN FRIEDRICH","title":"Chief Medical Officer","shares":4473,"price_per_share":3.96,"usd_value":17713,"security_title":"Common Stock","importance":15.01771308},{"ts":"2026-06-01","kind":"sec.insider.f","reporter":"Puri Raj K.","title":"Chief Regulatory Officer","shares":2508,"price_per_share":3.96,"usd_value":9932,"security_title":"Common Stock","importance":15.00993168},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"BILINSKY IGOR","title":"Chief Operating Officer","shares":8790,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"GRAF FINCKENSTEIN FRIEDRICH","title":"Chief Medical Officer","shares":8790,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Puri Raj K.","title":"Chief Regulatory Officer","shares":5469,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Vogt Frederick G","title":"Interim CEO & General Counsel","shares":41668,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-13","kind":"sec.filing","form_type":"4","title":"4 — IOVANCE BIOTHERAPEUTICS, INC. — 2026-05-13","url_slug":"/sec/cik-0001425205/4/0001104659-26-060356","accession_number":"0001104659-26-060356","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — IOVANCE BIOTHERAPEUTICS, INC. — 2026-05-12","url_slug":"/sec/cik-0001425205/schedule-13g/0000093751-26-000249","accession_number":"0000093751-26-000249","importance":55},{"ts":"2026-05-12","kind":"sec.13dg","reporter":"IOVANCE BIOTHERAPEUTICS, INC.","shares":17448108,"percent_of_class":4.2,"security_title":"SCHEDULE 13G","accession_number":"0000093751-26-000249","excerpt":null,"importance":55},{"ts":"2026-05-11","kind":"sec.insider.f","reporter":"Kirby Daniel Gordon","title":"Chief Commercial Officer","shares":2435,"price_per_share":3.7,"usd_value":9010,"security_title":"Common Stock","importance":15.0090095},{"ts":"2026-05-11","kind":"sec.insider.m","reporter":"Kirby Daniel Gordon","title":"Chief Commercial Officer","shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15}]}